(16) proposed to classify SCLC into four subtypes, A, N, Y, and P, based on four transcription factors (ASCL1, NeuroD1, YAP1, and POU2F3), advancing the development of precision therapy for SCLC. Here, ASCL1 is linked to small cell lung carcinoma.